Juan J Manríquez1, Sergio Silva. 1. Departamento de Dermatología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. jjmanriq@uc.cl
Abstract
INTRODUCTION: Loxoscelism represents a major public health problem for which there are no standard therapeutic interventions. OBJECTIVE: To review available scientific evidence on management of Loxoscelism METHOD: Systematic review of clinical studies. The search included multiple databases (Medline, Lilacs, Embase, Web of Sciences, Cinahl, Pre-Cinahl, Paperfirst, Proceedingsfirst, Dissertations and Theses, Toxline, Cochrane Library), handsearch of references, and contact with experts. RESULTS: Three clinical trials of poor methodological quality were identified from 5,207 references found. One trial (n = 31), concluded that the use of dapsone was associated with fewer local complications than surgical treatment. A second study (n = 46), concluded that the use of dapsone was superior to clorfenamine for skin lesions. A third study (n = 95) concluded that there was no differences between the use of oral dapsone, antivenom against anti-Loxosceles reclusa or a combination of both. CONCLUSIONS: There is insufficient evidence based on good quality studies to recommend treatment guidelines for individuals with skin or visceral loxoscelism.
INTRODUCTION: Loxoscelism represents a major public health problem for which there are no standard therapeutic interventions. OBJECTIVE: To review available scientific evidence on management of Loxoscelism METHOD: Systematic review of clinical studies. The search included multiple databases (Medline, Lilacs, Embase, Web of Sciences, Cinahl, Pre-Cinahl, Paperfirst, Proceedingsfirst, Dissertations and Theses, Toxline, Cochrane Library), handsearch of references, and contact with experts. RESULTS: Three clinical trials of poor methodological quality were identified from 5,207 references found. One trial (n = 31), concluded that the use of dapsone was associated with fewer local complications than surgical treatment. A second study (n = 46), concluded that the use of dapsone was superior to clorfenamine for skin lesions. A third study (n = 95) concluded that there was no differences between the use of oral dapsone, antivenom against anti-Loxosceles reclusa or a combination of both. CONCLUSIONS: There is insufficient evidence based on good quality studies to recommend treatment guidelines for individuals with skin or visceral loxoscelism.
Authors: Diego R Hijano; Daniel Otterson; Maysam R Homsi; Yin Su; Li Tang; Jeannette Kirby; Miguela A Caniza Journal: J Pediatr Hematol Oncol Date: 2019-01 Impact factor: 1.289
Authors: Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga Journal: Front Mol Biosci Date: 2021-06-17
Authors: Thaís Pereira da Silva; Fernando Jacomini de Castro; Larissa Vuitika; Nayanne Louise Costacurta Polli; Bruno César Antunes; Marianna Bóia-Ferreira; João Carlos Minozzo; Ricardo Barros Mariutti; Fernando Hitomi Matsubara; Raghuvir Krishnaswamy Arni; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Luiza Helena Gremski; Silvio Sanches Veiga Journal: Biomedicines Date: 2021-03-21